Proactive Investors - Run By Investors For Investors

Ascent Industries hails progress in cannabis research collaboration

The work is being undertaken by subsidiary Agrima Botanicals Corp and the university's plant biologist Dr Zamir K. Punja
Ascent Industries hails progress in cannabis research collaboration
Ascent is a licensed producer and dealer of cannabis

Ascent Industries Corp.(CSE:ASNT) updated on its cannabis research with the Simon Fraser University, saying a number of exciting discoveries have been made.

The work is being undertaken by subsidiary Agrima Botanicals Corp and the university's plant biologist Dr Zamir K. Punja.

READ: Ascent Industries poised to sell Pax's premium vape pen

Among the highlighted achievements is the identification of pathogens and molds affecting cannabis plants and DNA fingerprinting approaches for the identification of cannabis strains used in production.

Tissue culture methods have been developed that provide Ascent and its partners access to disease-free starting material from meristems and axillary buds in commercial scale volumes.

A DNA-based testing kit to distinguish male plants from female plants that were an outcome from this collaborative research is also currently on the market.

"In addition to strengthening our Intellectual Property (IP) portfolio, this project allows Ascent to develop and implement scientifically driven strategies to reduce crop loss risk and ensure batches of the highest quality by mitigating the impact of unwanted and deleterious cannabis pathogens," said Philip Campbell, CEO of Ascent Industries.

"In turn, this will help to ensure that we are able to produce exceptional products for use in our medical and consumer packaged goods.

"These results have wide-reaching applications to ours and our partner operations in Canada and abroad" concluded Campbell.

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full ASNT profile View Profile

Ascent Industries Corp. Timeline

Article
November 22 2018

Related Articles

The R&D programme is intended to address the increasing prevalence of obesity and diabetes using smart siRNA
October 30 2018
The health sciences company noted that the plan was formulated at a recently held two-day intensive workshop which together leading scientific teams from the QIMR Berghofer Medical Research Institute in Brisbane and Murdoch University in Perth
1540909388_Marijuana-stethoscope.jpg
October 30 2018
The firm wants to become the first publicly listed, globally focused, pure cannabis company
muffins and cannabis
November 29 2018
Dehydratech is essentially a delivery system that allows drugs and vitamins to get into the bloodstream quicker, while making them taste and smell better at the same time

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use